Navigation Links
Topaz Pharmaceuticals Names Dr. Mark Strobeck Chief Business Officer
Date:1/10/2011

HORSHAM, Pa., Jan. 10, 2011 /PRNewswire/ -- Topaz Pharmaceuticals Inc., a privately held specialty pharmaceutical company focused on dermatology and pediatrics, today announced that Mark Strobeck, Ph.D., has been appointed vice president and chief business officer. In his new role Dr. Strobeck will report to Robert Radie, president and chief executive officer, and will be responsible for managing business development, corporate strategy and financings.

"We are pleased to welcome to the Topaz management team Mark, a proven leader with a significant track record of success, who will lead our business development efforts," said Robert Radie, president and chief executive officer of Topaz. "With our lead product candidate nearing the final stage of development, we are building our commercial capabilities and interested in extending our business development reach."

Dr. Strobeck has decades of experience in the pharmaceutical and financial industry. Most recently, he served as chief business officer of Trevena, Inc., a pharmaceutical company dedicated to the discovery and development of GPCR biased ligands. Before joining Trevena he served as vice president of business development at GlaxoSmithKline (GSK) where he led the business development efforts for the company's clinical and preclinical stage assets. He also served as vice president of business development for the center of excellence for external drug discovery, a research and development division within GSK. Prior to this role Dr. Strobeck was a principal at SR One Ltd., the wholly owned venture capital arm of GSK.

Dr. Strobeck earned a Ph.D. in pharmacology and cell biophysics from the University of Cincinnati. He completed a post-doctoral fellowship in cardiovascular medicine at the University of Pennsylvania and has a bachelor's degree from St. Lawrence University.

About Topaz Pharmaceuticals Topaz Pharmaceuticals Inc. is a privately held specialty pharmaceutical company focused on developing and commercializing treatments primarily for pediatric and dermatology markets. The company's lead investigational product is a topical cream formulation of ivermectin currently under development for the treatment of head lice in children and adults which affects between six and 12 million people every year. The company has recently concluded two phase 3 studies of ivermectin for this potential indication and expects to file a new drug application this year. Topaz, headquartered in Horsham, PA, is backed by top-tier investors including Aisling Capital and Fidelity Biosciences. For more information about Topaz Pharmaceuticals Inc., please visit www.topazpharma.com. Contact Information E. Blair Schoeb Tel: 908-277-0386 blair@biotechcomm.com
'/>"/>

SOURCE Topaz Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Schiffrin Barroway Topaz & Kessler, LLP and Janet Jenner & Suggs, LLC Comment on Conagra Advisory Regarding Pot Pies Linked to Salmonella Outbreak
2. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
4. TOPAZ Technologies and Tecniplast USA Launch RFID Mobile Census
5. Topaz Pharmaceuticals Announces Positive Data from Topical Ivermectin Trials Presented at Society of Pediatric Dermatology
6. Shareholder Class Action Filed Against SciClone Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
7. TOPAZ Technologies and ML Weekes & Company Announce Partnership
8. Topaz Pharmaceuticals Names Bob Radie Chief Executive Officer
9. Topaz Pharmaceuticals Announces Completion of Pivotal Phase 3 Trials of Ivermectin Topical Cream
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... -- Radiology has become the number one diagnostic tool ... to the number one ranking as a result.  More ... as the most complete and reliable method for clinical ... pain an MRI may confirm a suspected herniated disc ... entirely different treatment protocols.  In these circumstances, patients need ...
(Date:5/9/2017)... May 9, 2017  Semler Scientific, Inc. (OTCQB: ... solutions to improve the clinical effectiveness and efficiency ... the first quarter ended March 31, 2017. ... our customers to identify when preventive care options ... events like heart attacks or strokes occur," said ...
(Date:5/6/2017)... 2017  Hill-Rom Holdings, Inc. (NYSE: HRC), has begun ... feet to its Welch Allyn campus. ... bring more than 100 new jobs to ... maintained a significant presence for more than 100 years. ... a large portion of which will be R&D and ...
Breaking Medicine Technology:
(Date:5/23/2017)... ... 2017 , ... London, May 23, 2017: Walter Schindler, the Founder and Managing ... Guest Speaker and Contributor to a weeklong series of classes, meetings, field trips and ... , Walter Schindler and SAIL Capital have received an increasing number ...
(Date:5/23/2017)... ... May 23, 2017 , ... Diagnotes, ... as a standard feature on its secure clinical communication platform. The platform allows ... video depending on the type and urgency of a situation. , “We ...
(Date:5/23/2017)... Francisco, California (PRWEB) , ... May 23, 2017 , ... ... results of its new survey in an infographic on the current state of anxiety ... U.S. respondents, familiar with anxiety, was conducted in April 2017 and benchmarked general anxiety ...
(Date:5/22/2017)... MO (PRWEB) , ... May 22, 2017 , ... Today, ... in Washington, MO with a public ribbon cutting ceremony. Since opening over ... offering an alternative to the emergency room. The new Our Urgent Care walk-in ...
(Date:5/22/2017)... San Francisco, CA (PRWEB) , ... May 22, ... ... site will sponsor a program on Wellocity to empower WeightZone Factor members ... of their medications, and get an excellent health education, all on their mobile ...
Breaking Medicine News(10 mins):